APA (7th ed.) Citation

Daaboul, H. E., Daher, C. F., Bodman-Smith, K., Taleb, R. I., Shehaby, W. N., Boulos, J., . . . El-Sibai, M. (2017). Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways.

Chicago Style (17th ed.) Citation

Daaboul, Hamid E., Costantine F. Daher, Kikki Bodman-Smith, Robin I. Taleb, Wassim N. Shehaby, Joelle Boulos, Carole Dagher, Mohamad A. Mroueh, and Mirvat El-Sibai. Antitumor Activity of β-2-himachalen-6-ol in Colon Cancer Is Mediated Through Its Inhibition of the PI3K and MAPK Pathways. 2017.

MLA (9th ed.) Citation

Daaboul, Hamid E., et al. Antitumor Activity of β-2-himachalen-6-ol in Colon Cancer Is Mediated Through Its Inhibition of the PI3K and MAPK Pathways. 2017.